Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Up and coming early phase CAR T-cell Therapy for treating relapsed or refractory large B-cell lymphoma.
Journal: Expert opinion on investigational drugs
Published: August 31, 2026
Real-world outcomes with BCMA- and GPRC5D-targeting bispecific antibodies in plasma cell leukemia.
Journal: Blood advances
Published: April 21, 2026
Real-World Outcomes with BCMA- and GPRC5D-Targeting Bispecific Antibodies in Plasma Cell Leukemia.
Journal: Blood advances
Published: April 21, 2026
Autoimmune and Inflammatory Diseases in Polycythemia Vera and Essential Thrombocythemia: Impact on Disease Outcomes and Comorbidities.
Journal: American journal of hematology
Published: April 08, 2026
Cancer history and second cancer risk in polycythemia vera and essential thrombocythemia.
Journal: Blood cancer journal
Published: March 30, 2026
The Safety and Efficacy of Commercial BCMA-Directed CAR T-Cell Therapy in Systemic AL Amyloidosis With Concurrent Myeloma.
Journal: American journal of hematology
Published: February 20, 2026
Rapid Peak Cilta-cel Expansion is Associated with Delayed Neurotoxicity in Multiple Myeloma.
Journal: Blood
Published: December 15, 2025
The impact of extramedullary and paraskeletal plasmacytomas on treatment outcomes in multiple myeloma treated with teclistamab: U.S. Myeloma Immunotherapy Consortium real-world experience.
Journal: Blood cancer journal
Published: June 30, 2025
The Mutational Landscape in Polycythemia Vera: Phenotype, Genotype, and Prognostic Correlates.
Journal: American journal of hematology
Published: March 23, 2025
Last Updated: 09/26/2026